The Center for Disease Control reports that 115.7 million total vaccinations for Covid-19 have taken place in the US as of yesterday. Joe Biden had called for 100 million shots in his first 100 days, but about 20 million of the reported 115.7 million took place under his predecessor. Between today’s vaccinations and those not yet reported from the last couple of days we may have already reached Biden’s goal or will tomorrow, which is 58 days from Biden taking office.
Also the CDC reports 151.1 doses of the three approved vaccines have been delivered meaning the rate of 2.3 million vaccinations per day or more can continue. The possibility of 200 million vaccinations in Biden’s first 100 days is starting to look feasible, maybe likely.
Nearly 23% of the total US population has now received at least one shot. Some 29.2% of adult US residents have received at least one dose. The number of those over 65 years of age who have been jabbed is now 66.8%. It is starting to look like at least 75% of the oldest Americans will agree to be vaccinated. Vaccine refusal may be fading somewhat, but it is certainly not gone.
Among the states, Alaska and New Mexico lead the way with Georgia and Alabama performing the most poorly.
The Biden Administration has agreed to send 4 million doses of the AstraZenaca vaccine to our nearest neighbors, Mexico and Canada. The AstraZenca vaccine has not been approved in the US so the American stockpile has not been of any use so far in fighting Covid.
The agreement will send 2.5 million shots to Mexico and 1.5 Million to Canada both of whom have approved the vaccine but whose vaccinations program have moved slowly due to lack of supply. If given as single shot regimens, this would be enough to vaccinate 4% of Canadians and 2% of Mexicans.
The deal to share the vaccine does not affect President Joe Biden's plans to have vaccine available for all adults in the United States by the end of May, a senior administration official said, and it does not reduce the supply of available vaccine in the United States…
The so-called “releasable” vaccines should be ready for use once they arrive in Mexico and Canada. Under the deal, the United States will share doses with the two countries now with the understanding that they will pay the United States back with doses in return. The official said that would take place later this year.
More Covid Vaccine Information
Here is the schedule for delivery of the currently approved vaccines:
www.msn.com/…
Pfizer-BioNTech
- March 31: 120 million doses
- May 31: 80 million doses
- July 31: 100 million doses
Moderna
- March 31: 100 million doses
- May 31: 100 million doses
- July 31: 100 million doses
Janssen (J&J)
- June 30: 100 million doses
- To be determined: An additional 100 million doses
Information from Israel shows that Pfizer’s vaccine is working slightly better than thought. Moderna’s and Novavx’s also living up to expectations. J&J and AstraZeneca are also effective at least against severe Covid.
Although clinical testing put the vaccine's effectiveness at 95%, real-world results from Israel suggest the vaccine could be at least 97% effective two weeks after the second dose. The firms are also testing a third dose of their original vaccine as a booster shot, and are working to update the vaccine to target the concerning strain first identified in South Africa…
Moderna's vaccine was 94.1% effective in clinical testing. Johnson & Johnson's (JNJ) single-shot vaccine was 66% effective. In a recent Phase 3 test, Novavax (NVAX) said its double-shot regimen was 96.4% effective against the original viral strain that causes Covid-19. AstraZeneca (AZN) has said its coronavirus vaccine was 70.4% effective, on average.
www.washingtonpost.com/…
John Magufuli, coronavirus-denying president of Tanzania, dies at 61The death was announced in a statement by Tanzanian Vice President Samia Suluhu Hassan, who cited “heart complications” as the cause. There had been earlier unconfirmed reports from opposition leaders, which Mr. Magufuli’s government denied, that he had been hospitalized in Nairobi for covid-19. He was last seen in public on Feb. 27.
Summary of Advanced Vaccine Efforts
www.nytimes.com/… Leading vaccines
Developer How It Works Phase Status
Pfizer-BioNTech mRNA 2/3 Approved in several countries.
Emergency use in U.S., E.U., other countries.
Moderna mRNA 3 Approved in Switzerland.
Emergency use in U.S., U.K., E.U., others.
Gamaleya Ad26, Ad5 3 Early use in Russia.
Emergency use in other countries.
Oxford-AstraZeneca ChAdOx1 2/3 Approved in Brazil.
Emergency use in U.K., E.U., other countries.
CanSino Ad5 3 Approved in China.
Emergency use in Mexico, Pakistan.
Johnson & Johnson Ad26 3 Emergency use in U.S., E.U., Bahrain.
Vector Institute Protein 3 Early use in Russia.
Novavax Protein 3
Sinopharm Inactivated 3 Approved in China, U.A.E., Bahrain.
Emergency use in other countries.
Sinovac Inactivated 3 Approved in China.
Emergency use in other countries.
Sinopharm-Wuhan Inactivated 3 Approved in China.
Limited use in U.A.E.
Bharat Biotech Inactivated 3 Emergency use in India, Iran, Zimbabwe.
Looking for an Appointment? Try these links:
| Day | Delivered | Total Shots | 1st Shot % of Pop | 2nd Shot % of Pop | |
| 3/17 | Wed | 151,108,445 |
115,730,008
+2,692,381 |
75,495,716 22.7%
+1,825,760 |
40,981,464 12.3% |
| 3/16 | Tue | 147,590,615 |
113,037,627
+2,299,771
|
73,669,956 22.2%
+1,534,340 |
39,989,196 12% |
| 3/15 | Mon | 142,918,525 |
110,737,856
+1,655,996 |
72,135,616 21.7%
+1,081,171 |
38,992,039 11.8% |
| 3/14 | Sun | 135,847,835 |
109,081,860
+2,021,586 |
71,054,445 21.4%
+1,410,460 |
38,286,605 11.5% |
| 3/13 | Sat | 135,847,835 |
107,060,274
+1,356,773 |
69,643,985 21.0%
+759,974 |
37,411,776 11.3% |
| 3/12 | Fri | 135,846,665 |
105,703,501
+4,575,496 |
68,884,011 20.7%
+2,918,706 |
36,883,178 11.1% |
| 3/11 | Thu | 133,337,525 |
101,128,005 +2,924,112 |
65,965,305 19.9% +1,893,631 |
35,000,159 10.5% |
| 3/10 | Wed | 131,131,470 |
98,203,893 +2,482,603 |
64,071,674 19.3% +1,620,524 |
33,863,127 10.2% |
| 3/9 | Tue | 127,869,155 |
95,721,290 +2,028,692 |
62,451,150 18.8% +1,424,025 |
32,904,161 9.9% |
| 3/8 | Mon | 123,232,775 |
93,692,598 +1,602,746 |
61,027,125 18.4% +1,021,894 |
32,079,368 9.7% |
| 3/7 | Sun | 116,378,615 |
92,089,852 +1,738,102 |
60,005,231 18.1% +1,131,521 |
31,285,186 9.4% |
| 3/6 | Sat | 116,363,405 |
90,351,750 +2,439,427 |
58,873,710 17.7%
+1,514,861 |
30,686,881 9.2% |
| 3/5 | Fri | 116,355,405 |
87,912,323
+2,904,229 |
57,358,849 17.3%
+1,811,152 |
29,776,160 9.0% |
| 3/4 | Thu | 114,133,115 |
85,008,094 +2,435,246 |
55,547,697 16.7% +1,512,027 |
28,701,201 8.6% |
| 3/3 | Wed | 109,905,530 |
82,572,848 +2,032,374 |
54,035,670 16.3% +1,180,091 |
27,795,980 8.4% |
| 3/2 | Tue | 107,028,890 |
80,540,474 +1,908,873 |
52,855,579 15.9% +1,100,132 |
26,957,804 8.1% |
| 3/1 | Mon | 102,353,940 |
78,631,601 +1,731,614 |
51,755,447 15.6% +1,022,450 |
26,162,122 7.9% |
| 2/28 | Sun | 96,402,490 |
76,899,987 +1,663,984 |
50,732,997 15.3%
+960,817
|
25,466,405 7.7% |
| 2/27 |
|
J&J vaccine |
approved |
||
|
1/19
1/18 1/14 |
|
pre-Biden
Moderna Pfizer/Bio |
20,110,911
authorized authorized |
covid.cdc.gov/… |
(The CDC has a 72 hour window for reporting vaccine numbers)
